Drug Delivery (Jan 2021)

A mechanism for improved talc pleurodesis via foam delivery

  • T. A. Lima,
  • R. A. Coler,
  • G. W. Laub,
  • S. Sexton,
  • L. Curtin,
  • K. M. Laub,
  • N. J. Alvarez

DOI
https://doi.org/10.1080/10717544.2021.1895910
Journal volume & issue
Vol. 28, no. 1
pp. 733 – 740

Abstract

Read online

Talcum powder is recognized as the leading drug for pleurodesis, a treatment of choice for malignant pleural effusions. Recently, it was shown that hydrogel foam delivery systems significantly enhanced the number of adhesions between the chest wall and the lung in a New Zealand rabbit model due to the sol-gel transition. However, many questions still remain regarding the cause of improved efficacy, such as: (1) Would only hydrogel foams improve the efficacy of talc pleurodesis? (2) Is it possible to achieve the same efficacy of hydrogels using non-hydrogel foams? 3) What are the physicochemical properties that can be correlated to the efficacy of talc pleurodesis? In this study, we use non-hydrogel foam formulations to determine the efficacy of pleurodesis. Foam stability and rheology of the formulations were correlated to adhesion formation. The results clearly suggest a correlation of pleurodesis efficacy to the viscosity and modulus of the foam delivery system.

Keywords